Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 22 peer-reviewed journal articles Updated
Neuromuscular Medicine · Pompe Disease

Building Your Care Team and Daily Life

At a Glance

People with Pompe disease often benefit from one coordinated team that includes muscle, breathing, heart, rehabilitation, nutrition, swallowing, and genetics specialists. Daily care may also include carefully paced exercise, monitoring for complications, and emotional support.

Managing Pompe disease is not just about receiving infusions; it is about building a comprehensive support system that addresses the whole person. Because the condition affects multiple systems, your care should be coordinated by a multidisciplinary team—a group of specialists who work together to monitor your health from every angle [1][2]. Remember that this guide complements, but does not replace, individualized advice from your clinician.

Your Multidisciplinary Care Team

A “center of excellence” or a specialized neuromuscular clinic is typically the best home for your care. Your team should include:

  • Neuromuscular Specialist or Metabolic Geneticist: The “quarterback” who manages the overall disease and coordinates your Enzyme Replacement Therapy (ERT) [1].
  • Pulmonologist: Focused on your breathing strength and sleep health [3].
  • Cardiologist: Essential for heart monitoring in infants and for long-term rhythm checks in adults [4].
  • Physical (PT) and Occupational (OT) Therapists: Specialists who help maintain mobility and adapt daily activities [5][6].
  • Dietician and Speech-Language Pathologist: To address nutrition, feeding, and swallowing difficulties [7][8].
  • Genetic Counselor: To help with family planning and understanding the genetics of the condition [9].

Daily Management: Movement and Nutrition

Physical therapy in Pompe disease is unique. While exercise is important, it must be carefully managed to avoid overworking weakened muscles [6].

  • Submaximal Exercise: The goal is often “submaximal” aerobic activity—exercise that improves endurance without pushing you to exhaustion. This must be guided by a neuromuscular physical therapist, as it is not a universal prescription for every patient [6][10]. If you experience excessive fatigue, severe pain, or breathlessness, prompt reassessment is needed.
  • Respiratory Training: Some patients benefit from specific exercises that strengthen the muscles used for breathing, though this must also be strictly evaluated by a specialist [5][11].
  • Feeding and Swallowing: If muscle weakness makes eating difficult, it is crucial to request a formal clinical swallow evaluation from a speech-language pathologist to assess aspiration risk. Simple “myofunctional exercises” are not a substitute for this assessment [12].

Overlooked Aspects of Long-Term Care

As treatment helps people with Pompe disease live longer, we are learning more about symptoms that occur outside the main muscle groups. These assessments are often risk-based rather than universal.

  • Hearing Health: Some children with Pompe disease develop sensorineural hearing loss, which is why regular hearing tests are a standard part of pediatric survivor care [13].
  • Bone Health: Adults with LOPD have a higher risk of osteopenia (low bone density) or osteoporosis, which can lead to fractures. Your team should monitor your vitamin D levels and may recommend DEXA scans to check bone strength [14][15].
  • Gastrointestinal (GI) Issues: Many people with Pompe experience GI symptoms like bloating, diarrhea, or reflux. These symptoms are often severe and may not be fully resolved by ERT alone, requiring specific dietary or medical management [16].
  • Spine Health: Weakness in the trunk muscles can lead to scoliosis (curving of the spine) or changes in posture that can eventually interfere with breathing [17][18].

The Psychosocial Journey

A diagnosis of Pompe disease—especially when found through newborn screening—carries a heavy emotional weight.

  • The “Patient-in-Waiting”: For families of children with LOPD who do not yet have symptoms, the surveillance period can be a source of intense anxiety. Parents often describe a constant search for the first sign of weakness, a feeling sometimes called “scan anxiety” or being “in limbo” [19][20].
  • Coping Strategies: Having a clear, written surveillance plan from your doctor can help reduce this uncertainty. Knowing exactly what symptoms to look for and what tests will be done can provide a sense of control [21][22].
  • Support Systems: Caregiver burnout is a real risk. Connecting with patient advocacy groups and seeking support from a social worker or counselor who understands rare diseases can be vital for your long-term well-being [9][22].

Common questions in this guide

Which specialists should be involved in Pompe disease care?
A neuromuscular specialist or metabolic geneticist often coordinates care, with input from a pulmonologist, cardiologist, physical and occupational therapists, dietitian, speech-language pathologist, and genetic counselor. The exact team depends on the person's age, symptoms, Pompe subtype, and treatment needs.
How can I exercise safely with Pompe disease?
Some people may benefit from submaximal aerobic activity or breathing-muscle exercises, but the plan should be set and monitored by a physical therapist familiar with neuromuscular disease. Excessive fatigue, severe pain, or breathlessness should prompt a call to the care team and reassessment.
Why is a swallowing evaluation important in Pompe disease?
Muscle weakness can make eating and swallowing difficult and can increase the risk of food or liquid entering the airway. A formal clinical swallow evaluation by a speech-language pathologist can assess that risk and guide safer nutrition; simple exercises should not replace the evaluation.
What health checks should people with Pompe disease have over time?
Monitoring may include breathing and heart checks, hearing tests for children, bone health assessment such as vitamin D testing or a DEXA scan for some adults, and evaluation of the spine and posture. The schedule should be individualized by the care team because not every test is needed at every visit.
Does enzyme replacement therapy address every Pompe disease symptom?
Enzyme replacement therapy is an important part of Pompe disease treatment, but it may not resolve every problem, especially symptoms such as bloating, diarrhea, or reflux. Ongoing dietary or medical management and support from relevant specialists may still be needed.
How can families cope with uncertainty and caregiver burnout in Pompe disease?
A written surveillance plan can clarify which symptoms and tests to watch for, which may make periods of uncertainty easier to manage. Patient advocacy groups, social workers, and counselors familiar with rare diseases can provide practical and emotional support.
Should Pompe disease care be provided at a specialized center?
A center of excellence or specialized neuromuscular clinic can coordinate multiple specialists and may be especially useful when care is complex. Ask about experience with infantile-onset or late-onset Pompe disease and whether the team can consult a national Pompe center.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Who is the primary coordinator of my multidisciplinary team, and how do they ensure my cardiologist, pulmonologist, and therapist are in sync?
  2. 2.How much experience does this center have specifically with my subtype (IOPD or LOPD), and can you consult with a national Pompe center of excellence if a complex issue arises?
  3. 3.What are the specific limits my physical therapist should use during our sessions to prevent overexertion?
  4. 4.How often will we screen for overlooked issues like hearing loss, scoliosis, and bone density (osteopenia)?
  5. 5.Can we develop a written 'surveillance plan' that outlines exactly which tests will be done and what results would trigger a change in treatment?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (22)
  1. 1

    The European reference network for metabolic diseases (MetabERN) clinical pathway recommendations for Pompe disease (acid maltase deficiency, glycogen storage disease type II).

    Parenti G, Fecarotta S, Alagia M, et al.

    Orphanet journal of rare diseases 2024; (19(1)):408 doi:10.1186/s13023-024-03373-w.

    PMID: 39482698
  2. 2

    Recommendations for Infantile-Onset and Late-Onset Pompe Disease: An Iranian Consensus.

    Fatehi F, Ashrafi MR, Babaee M, et al.

    Frontiers in neurology 2021; (12()):739931 doi:10.3389/fneur.2021.739931.

    PMID: 34621239
  3. 3

    Monitoring and Management of Respiratory Function in Pompe Disease: Current Perspectives.

    El Haddad L, Khan M, Soufny R, et al.

    Therapeutics and clinical risk management 2023; (19()):713-729 doi:10.2147/TCRM.S362871.

    PMID: 37680303
  4. 4

    Pompe Disease: From a Cardiovascular Lens.

    Ali A, Thirumavalavan D, Catanzaro JN, et al.

    Cardiology in review 2026; doi:10.1097/CRD.0000000000001432.

    PMID: 42596035
  5. 5

    Rehabilitation management of Pompe disease, from childhood trough adulthood: A systematic review of the literature.

    Corrado B, Ciardi G, Iammarrone CS

    Neurology international 2019; (11(2)):7983 doi:10.4081/ni.2019.7983.

    PMID: 31281600
  6. 6

    The role of rehabilitation in the management of late-onset Pompe disease: a narrative review of the level of evidence.

    Iolascon G, Vitacca M, Carraro E, et al.

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2018; (37(4)):241-251.

    PMID: 30944902
  7. 7

    Insight into the phenotype of infants with Pompe disease identified by newborn screening with the common c.-32-13T>G "late-onset" GAA variant.

    Rairikar MV, Case LE, Bailey LA, et al.

    Molecular genetics and metabolism 2017; (122(3)):99-107 doi:10.1016/j.ymgme.2017.09.008.

    PMID: 28951071
  8. 8

    Pompe disease gene therapy: neural manifestations require consideration of CNS directed therapy.

    Byrne BJ, Fuller DD, Smith BK, et al.

    Annals of translational medicine 2019; (7(13)):290 doi:10.21037/atm.2019.05.56.

    PMID: 31392202
  9. 9

    Pompe Disease: A Review of Diagnosis, Molecular Genetics, and Treatment Management.

    Adadi N, El Brouzi MY

    Current cardiology reviews 2026; (22(3)):e1573403X377990 doi:10.2174/011573403X377990250818051032.

    PMID: 40947720
  10. 10

    Exercise, nutrition and enzyme replacement therapy are efficacious in adult Pompe patients: report from EPOC Consortium.

    Angelini C

    European journal of translational myology 2021; (31(2)) doi:10.4081/ejtm.2021.9798.

    PMID: 33942602
  11. 11

    Respiratory muscle training with enzyme replacement therapy improves muscle strength in late - onset Pompe disease.

    Jevnikar M, Kodric M, Cantarutti F, et al.

    Molecular genetics and metabolism reports 2015; (5()):67-71 doi:10.1016/j.ymgmr.2015.09.007.

    PMID: 28649546
  12. 12

    Orofacial features and pediatric dentistry in the long-term management of Infantile Pompe Disease children.

    Galeotti A, De Rosa S, Uomo R, et al.

    Orphanet journal of rare diseases 2020; (15(1)):329 doi:10.1186/s13023-020-01615-1.

    PMID: 33228748
  13. 13

    Evaluation of Experienced Clinical Events in Pompe Disease Based on Real-life Data.

    Erdem Karapınar F, Yazıcı H, Yoldaş Çelik M, et al.

    Neuropediatrics 2026; (57(2)):121-130 doi:10.1055/a-2777-2932.

    PMID: 41453391
  14. 14

    Effects of enzyme replacement therapy on bone density in late onset Pompe disease.

    Avanti M, Martin A, Columbres RC, et al.

    Molecular genetics and metabolism 2023; (140(3)):107644 doi:10.1016/j.ymgme.2023.107644.

    PMID: 37515933
  15. 15

    Rare Variants in Autophagy and Non-Autophagy Genes in Late-Onset Pompe Disease: Suggestions of Their Disease-Modifying Role in Two Italian Families.

    Napolitano F, Bruno G, Terracciano C, et al.

    International journal of molecular sciences 2021; (22(7)) doi:10.3390/ijms22073625.

    PMID: 33807278
  16. 16

    New Insights into Gastrointestinal Involvement in Late-Onset Pompe Disease: Lessons Learned from Bench and Bedside.

    Korlimarla A, Lim JA, McIntosh P, et al.

    Journal of clinical medicine 2021; (10(15)) doi:10.3390/jcm10153395.

    PMID: 34362174
  17. 17

    Early-onset of symptoms and clinical course of Pompe disease associated with the c.-32-13 T > G variant.

    Herbert M, Case LE, Rairikar M, et al.

    Molecular genetics and metabolism 2019; (126(2)):106-116 doi:10.1016/j.ymgme.2018.08.009.

    PMID: 30655185
  18. 18

    Critical Airway Stenosis in an Adolescent Male With Pompe Disease and Thoracic Lordosis: A Case Report.

    Brenn BR, Theroux MT, Shah SA, et al.

    A & A case reports 2017; (9(7)):199-203 doi:10.1213/XAA.0000000000000564.

    PMID: 28542051
  19. 19

    Newborn screening for Pompe disease: impact on families.

    Pruniski B, Lisi E, Ali N

    Journal of inherited metabolic disease 2018; (41(6)):1189-1203 doi:10.1007/s10545-018-0159-2.

    PMID: 29594646
  20. 20

    Newborn screening for Pompe disease: Parental experiences and follow-up care for a late-onset diagnosis.

    Prakash S, Penn JD, Jackson KE, Dean LW

    Journal of genetic counseling 2022; (31(6)):1404-1420 doi:10.1002/jgc4.1615.

    PMID: 35915971
  21. 21

    Management of Confirmed Newborn-Screened Patients With Pompe Disease Across the Disease Spectrum.

    Kronn DF, Day-Salvatore D, Hwu WL, et al.

    Pediatrics 2017; (140(Suppl 1)):S24-S45 doi:10.1542/peds.2016-0280E.

    PMID: 29162675
  22. 22

    Navigating the Emotional and Practical Challenges of Newborn Screening for Late-Onset Pompe Disease: Insights From Parental Perspectives.

    Boueri M, Paltzer A, Huggins E, et al.

    Pediatric neurology 2025; (172()):94-100 doi:10.1016/j.pediatrneurol.2025.08.003.

    PMID: 40912068

This page is for informational purposes only and does not constitute medical advice. Your Pompe disease team should tailor exercise, swallowing assessments, monitoring, and treatment to your needs.

Get notified when new evidence is published on Glycogen storage disease due to acid maltase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.